Sana Biotechnology, Inc.

SANA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$267-$283-$269-$356
Dep. & Amort.$17$25$16$11
Deferred Tax$0$0$0$0
Stock-Based Comp.$38$36$38$22
Change in WC-$1$19$8$10
Other Non-Cash-$10-$49-$82$62
Operating Cash Flow-$223-$254-$290-$251
Investing Activities
PP&E Inv.$0-$20-$21-$30
Net Acquisitions$0-$0-$0$0
Inv. Purchases$0-$158-$79-$491
Inv. Sales/Matur.$0$350$310$280
Other Inv. Act.$17$0$0-$5
Investing Cash Flow$17$172$211-$246
Financing Activities
Debt Repay.$8$0$0$0
Stock Issued$181$32$5$632
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$11$0$0$0
Financing Cash Flow$200$32$5$632
Forex Effect$0$0$0$0
Net Chg. in Cash-$6-$50-$75$135
Supplemental Information
Beg. Cash$137$187$262$127
End Cash$131$137$187$262
Free Cash Flow-$257-$274-$311-$281
Sana Biotechnology, Inc. (SANA) Financial Statements & Key Stats | AlphaPilot